The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2018 | Lung cancer screening rates in the USA are too low
Lung cancer is the leading cause of cancer mortality in the United States, and low-dose CT scans are advised as a screening tool for high-risk groups such as smokers. In this video, recorded at the American Society of Oncology (ASCO) 2018 Annual Meeting in Chicago, IL, Danh Pham, MD, of the University of Louisville, Louisville, KN, discusses his recent study, which used data from the American College of Radiology’s Lung Cancer Screening Registry to show that only 1.9% of smokers at risk of lung cancer were screened in 2016. While this figure rose slightly to 3.4% in 2017, these numbers are still extremely low, especially when compared to those for other routine screening procedures such as colonoscopies. Dr Pham also emphasizes the importance of increased awareness and access to lung cancer screening in the future.
